Stanford’s Department of Neurology is looking for people between the ages of 50 and 80 who have Parkinson’s disease to participate in a clinical trial investigating the tolerability, feasibility, and safety of young plasma infusions as a future potential treatment.

The study requires 14 visits of participation over 3 months and involves a series of cognitive tasks, motor assessments and blood draws. Participants must be diagnosed with PD for at least 2 years and able to walk unassisted. The findings from this study may help with the development of therapies to treat cognitive or motor dysfunction in Parkinson’s disease.

For more information, please contact Amaris by email or phone 650-723-6709.